ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      58,051.32
      2.48%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Esperion Therapeutics Inc (ESPR)

      7. Esperion Therapeutics Inc (ESPR) News

      ESPR

      Esperion Therapeutics (ESPR)

      Esperion Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ESPR
      DateTimeSourceHeadlineSymbolCompany
      07/01/20134:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      07/01/20134:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      07/01/20134:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      07/01/20134:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      07/01/20134:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      07/01/20134:18PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ESPREsperion Therapeutics Inc
      06/26/20138:00AMBusiness WireEsperion Therapeutics, Inc. Announces Pricing of Initial Public OfferingNASDAQ:ESPREsperion Therapeutics Inc
      06/26/20138:00AMBusiness WireEsperion Therapeutics, Inc. Announces Pricing of Initial Public OfferingNASDAQ:ESPREsperion Therapeutics Inc
      01/09/20049:06AMPR Newswire (US)Esperion to Present at JPMorgan Healthcare ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      01/08/20043:02PMPR Newswire (US)Esperion alcanza un acuerdo para retirar la demanda por especulación contra varias firmas de inversiónNASDAQ:ESPREsperion Therapeutics Inc
      01/08/20049:38AMPR Newswire (US)Esperion Announces Settlement of Short-Swing Profit LawsuitNASDAQ:ESPREsperion Therapeutics Inc
      01/08/20049:00AMPR Newswire (US)Esperion Announces Settlement of Short-Swing Profit LawsuitNASDAQ:ESPREsperion Therapeutics Inc
      12/21/20031:06PMPR Newswire (US)Pfizer to Acquire Esperion Therapeutics to Extend Its Research Commitment In Cardiovascular DiseaseNASDAQ:ESPR
      12/18/20035:45AMPR Newswire (US)Esperion consigue unos resultados positivos en el segundo estudio en Fase 1 del producto ETC-642NASDAQ:ESPR
      12/16/20038:00AMPR Newswire (US)Esperion Reports Positive Results for Second Phase 1 Study of ETC-642NASDAQ:ESPREsperion Therapeutics Inc
      12/16/20038:00AMPR Newswire (US)Esperion Reports Positive Results for Second Phase 1 Study of ETC-642NASDAQ:ESPR
      12/04/20031:41PMPR Newswire (US)Esperion anuncia buenos resultados en la fase 1 del estudio de ETC-1001NASDAQ:ESPR
      12/04/20038:00AMPR Newswire (US)Esperion Announces Positive Results of Phase 1 Study of ETC-1001NASDAQ:ESPR
      12/04/20038:00AMPR Newswire (US)Esperion Announces Positive Results of Phase 1 Study of ETC-1001NASDAQ:ESPREsperion Therapeutics Inc
      11/10/20035:00PMPR Newswire (US)Esperion to Present at the CIBC World Markets Healthcare ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      11/06/20039:31AMPR Newswire (US)MORNING UPDATE: Man Securities Issues Alerts for BRCD, ESPR, KRB, AV, and MXONASDAQ:ESPREsperion Therapeutics Inc
      11/05/20034:57AMPR Newswire (US)Esperion dará una rueda de prensa sobre las actualizaciones del estudio sobre ETC-216NASDAQ:ESPREsperion Therapeutics Inc
      11/04/20034:00PMPR Newswire (US)Esperion Announces Publication of Results From Phase 2 Study of ETC-216 and Upcoming Conference CallNASDAQ:ESPREsperion Therapeutics Inc
      11/04/20034:00PMPR Newswire (US)Esperion Announces Publication of Results From Phase 2 Study of ETC-216 and Upcoming Conference CallNASDAQ:ESPREsperion Therapeutics Inc
      11/04/20037:46AMPR Newswire (US)Esperion dará una rueda de prensa sobre las actualizaciones del estudio sobre ETC-216NASDAQ:ESPR
      11/03/200310:45PMPR Newswire (US)Esperion to Hold Conference Call to Provide Update On Findings From Study of ETC-216NASDAQ:ESPR
      11/03/20039:19PMPR Newswire (US)Esperion to Hold Conference Call to Provide Update On Findings From Study of ETC-216NASDAQ:ESPR
       Showing the most relevant articles for your search:NASDAQ:ESPR